Transitioning pre-clinical glioblastoma models to clinical settings with biomarkers identified in 3D cell-based models: A systematic scoping review

Glioblastoma (GBM) remains incurable despite the overwhelming discovery of 2-dimensional (2D) cell-based potential therapeutics since the majority of them have met unsatisfactory results in animal and clinical settings. Incremental empirical evidence has laid the widespread need of transitioning 2D...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Brandon Wee Siang Phon, Muhamad N.A. Kamarudin, Saatheeyavaane Bhuvanendran, Ammu K. Radhakrishnan
Formato: article
Lenguaje:EN
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://doaj.org/article/22078187bebb4e2f852bcf6562545ce0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!